Your browser doesn't support javascript.
loading
Interaction between meropenem and valproate: Not to overlook
IJEHSR-International Journal of Endorsing Health Science Research. 2016; 4 (1): 27-31
en Inglés | IMEMR | ID: emr-178857
ABSTRACT
Background Valproic acid is commonly used to treat various types of seizures and follows nonlinear pharmacokinetics with a therapeutic range of 50 - 150 microg/ml. Several retrospective studies have reported that concomitant administration of VPA and carbapenem lead to decrease in VPA levels significantly and results in failure of seizure control. Different studies suggest the mechanism of interaction as [i] carbapenem may inhibit the gastrointestinal absorption of VPA [ii] meropenem accelerated the glucuronidation of VPA to VPA glucuronide [VPA-G] and inhibited the hydrolysis of VPA-G back to the VPA thus increasing the clearance of VPA and VPA-G and [iii] due to fast erythrocyte distribution of VPA by carbapenem, VPA levels has been reduced
Asunto(s)
Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Tienamicinas / Ácido Valproico / Centros de Atención Terciaria Tipo de estudio: Informe de Casos Límite: Niño / Humanos / Masculino Idioma: Inglés Revista: Int. J. Endorsing Health Sci. Res. Año: 2016

Similares

MEDLINE

...
LILACS

LIS

Buscar en Google
Índice: IMEMR (Mediterraneo Oriental) Asunto principal: Tienamicinas / Ácido Valproico / Centros de Atención Terciaria Tipo de estudio: Informe de Casos Límite: Niño / Humanos / Masculino Idioma: Inglés Revista: Int. J. Endorsing Health Sci. Res. Año: 2016